Navigation Links
Chiltern Enhances Its Portfolio of Electronic Data Capture (EDC) Services With the Addition of Hosting and eCRF Design Services for DataLabs (by ClinPhone) and Medidata Rave(R) Certification
Date:6/22/2008

LONDON, June 23 /PRNewswire/ -- Chiltern, a leading global research organization announced today the integration of DataLabs v4.1.4 into its suite of clinical trial management applications providing sponsors and investigators with enhanced services for the collection and management of electronic clinical trial data. Chiltern has completed installation and validation of the DataLabs EDC system according to 21CRF Part 11 requirements. eCRF hosting services are available (with full server redundancy) at Chiltern locations in Bristol Tennessee (US) and London (UK) and the programming of several eCRFs by Chiltern is currently underway. Chiltern's in-house EDC capabilities now include provision of all eClinical services relating to DataLabs by ClinPhone with resulting efficiency savings for our sponsors.

In April 2008, Chiltern staff have also achieved Medidata Rave(R) certification using Medidata's ASPire to Win Program. As a result and in addition to our well established existing Rave(R) services relating to EDC training and data management, Chiltern now also has the capability to program eCRFs using Rave(R) and collaborates with Medidata for support services such as hosting.

"Chiltern continues to be at the vanguard of EDC technology implementation," said Jim Esinhart, VP Global Biometrics, "and we are pleased to be able to assist our sponsors with our detailed knowledge and experience in clinical trials combined with the flexibility to utilize two of the leading EDC systems in Medidata Rave(R) and ClinPhone EDC. Where our sponsors express a preference for other systems, Chiltern's general EDC experience also allows us to continue to work with other EDC vendors in service areas such as EDC training, data management and monitoring. In particular, Chiltern has a strong track record with PhaseForward's InForm(TM) software."

About Chiltern:

Established in 1982, Chiltern is a leading global Contract Research Organization with extensive exp
'/>"/>

SOURCE Chiltern
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Chiltern Expands Its Global Reach to Latin America
2. Chiltern Announces New Expansion in Portugal
3. Chiltern Opens a New Office in Russia
4. Chiltern Will Sponsor and Present at the 17th Annual Partnerships With CROs Meeting in Las Vegas, April 14 - 16, 2008.
5. Chiltern Wins Top Prize
6. Chiltern Announced Today That it has Acquired the Business of Drug Development Solutions (DDS)
7. Diana Hatsis of Chiltern Will Present at the Joint Commission on Allied Health Personnel in Ophthalmology (JCAHPO) 35th Annual Continuing Education Program Held in Conjunction With the American Academy of Ophthalmology (AAO) Annual Meeting
8. Chiltern to Participate at the Partnerships in Clinical Trials Conference in Amsterdam
9. Chiltern Announces Acquisition of an Independent USA Based Clinical Research Organization, Clinical Trial Management Services, Inc.
10. Chiltern Appoints Steve Albrecht to Support Further Expansion in Late Phase
11. Marco Romano, MD Joins Chiltern as Medical Director, Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)... ORLEANS, Dec. 5 There have been significant scientific ... experts continue to gain a better understanding of how ... options and provide patients with the best care. Research ... American Society of Hematology explores optimal induction therapies for ...
(Date:12/5/2009)... Dec. 5 Leukemia and myeloproliferative disorders are ... today at the 51st Annual Meeting of the ... options and improved diagnostic methods for patients suffering ... acute lymphoblastic leukemia, and myelofibrosis that are based ...
(Date:12/5/2009)... International Solutions, an innovative new international private medical insurance plan which ... to offering customers the flexibility to add or remove a wide ... enables customers to tailor their benefits to complement those already offered ... ...
(Date:12/4/2009)... Care Investment Trust Inc. (NYSE: CRE ) ("Care" ... declared a dividend of $0.17 per share of common stock. ... of record on December 14, 2009. ,, ... a real estate investment and finance company investing in healthcare-related real ...
(Date:12/4/2009)... WASHINGTON, Dec. 4 The American Association of Homes and ... that the Community Living and Supportive Services (CLASS) provisions ... provisions are essential for providing support to elders, people with ... to pass a health care reform bill that will make ...
Breaking Medicine News(10 mins):Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 3Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 4Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 5Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 6Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 7Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9Health News:AVIVA's Private Health Insurance Products Solutions Go International 2Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2
... at Washington University has highlighted a new combination drug ... modality claims to even restore normal breathing in affected ... have revealed promising findings, the results of which can ... dual drug combination is believed to enhance airway function ...
... Institute of General Medical Sciences, one of the National ... award of national Models of Infectious Disease Agent Study ... and Harvard Pilgrim Health Care-led research team. ... powerful mathematical and statistical modeling techniques. These techniques would ...
... every possibility that there could be a common gene which ... the // Indiana University School of Medicine. This could also ... Genetic information is sought from about 1,000 families in which ... ,The genetic link with regard to the ...
... Weizmann Institute of Science’s researchers have discovered ancient DNA ... Proceedings of the National Academy of Sciences// (PNAS) has ... provides information with regard to population dynamics, evolution, diets ... and animals. ,Contaminated DNA may also ...
... University of Arizona has reported in the Journal Osteoporosis ... regular exercise makes their bone fit and prevents bone ... highly reduces the risk of developing Osteoporosis in older ... age people and is more prominent in women than ...
... RotaTeq for rotavirus has been approved by the US. The ... lives of about 500,000 children across the world annually. // ... the medicine's maker tested the vaccine on more than 70,000 ... ,Rotavirus is a highly contagious virus that causes severe ...
Other Medicine News:Health News:Detecting Epidemics using statistics 2
(Date:12/3/2009)... 3 Pharmacyclics, Inc. (Nasdaq: PCYC ), a ... molecule drugs for the treatment of immune mediated diseases ... webcast and conference call on, Tuesday, December 8, 2009 ... Pacific Time) to discuss clinical data regarding its HDAC ...
(Date:12/3/2009)... Dec. 3 Radiology imaging leader MEDRAD, Inc. ... 2009 Radiology Society of North America in Chicago. ... first radiology informatics capabilities of its kind, is ... Certegra(TM) Informatics Platform . ,, ...
(Date:12/3/2009)... FORT WORTH, Texas, Dec. 3 ... Board: WNDM), a rapidly growing provider of specialty ... Health Industry Representative Association (HIRA) to serve as ... market the company,s core CellerateRx® product ...
Breaking Medicine Technology:Pharmacyclics to Host Webcast and Conference Call to Discuss Clinical Updates on Its HDAC and BTK Program as Presented at The American Society of Hematology Meeting Dec. 6 & 7 2MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 2MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 3Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 2Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 3WinCo Foods Voluntarily Recalls Beef and Ground Beef Sold at Some Stores Between May 9 and May 15 2009 Due to Possible Contamination 50449 1WinCo Foods Voluntarily Recalls Beef and Ground Beef Sold at Some Stores Between May 9 and May 15 2009 Due to Possible Contamination 50449 2Winnipeg Veterinary Company Pharm Vet Produces Essential Oil Infused Mosquito Spray Thats a Welcome and Safe Alternative to Controversial Deet Based R 50447 1Surgeons Warn 3A Skateboarding Tough on Feet Ankles 50446 1Surgeons Warn 3A Skateboarding Tough on Feet Ankles 50446 2
... Systems, Inc.,(OTC Bulletin Board: ABOS) announced today that ... and Drug Administration ("FDA") of an,Investigational Device Exemption ... Arbios, extracorporeal (outside the body) liver assist,device for ... liver disease., "We are pleased to have ...
... PHILADELPHIA, May 12 GlaxoSmithKline (GSK),in collaboration with ... cancer research network, and one of its member ... announced the start,of a global Phase III study ... the,treatment of early breast cancer. Neo-ALTTO (Neoadjuvant Lapatinib ...
Other Medicine Technology:Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device 2Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device 3Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device 4Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device 5TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 2TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 3TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 4TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 5TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 6TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 7
200 L, Bulk, clear Recommended for 20, 25, 50, 100 and 200 L pipettes. ...
Designed to handle larger volumes, this tip has all the features of the ART XLP but has been modified to draw a full 200 ul....
Designed for the Eppendorf and Pipetman 100 ul pipettors, this tip features MicroPoint design, reference mark at 10 ul and a yellow tip design for the most universal fit....
The ultra micro tip for the new Eppendorf 2000/2100 series ultra micro pipettors provides accurate drawing and dispensing everytime....
Medicine Products: